RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,301,245 | +163.3% | 144,002 | +89.4% | 0.00% | – |
Q2 2023 | $1,253,636 | -79.9% | 76,024 | -78.3% | 0.00% | -100.0% |
Q1 2023 | $6,237,560 | +7.4% | 349,639 | +75.3% | 0.00% | 0.0% |
Q4 2022 | $5,809,527 | +2564.9% | 199,503 | +954.3% | 0.00% | – |
Q1 2022 | $218,000 | -13.1% | 18,923 | +60.8% | 0.00% | – |
Q1 2021 | $251,000 | -4.6% | 11,770 | +33.2% | 0.00% | – |
Q4 2020 | $263,000 | +24.1% | 8,838 | -7.0% | 0.00% | – |
Q2 2020 | $212,000 | +15.8% | 9,505 | -20.9% | 0.00% | – |
Q1 2020 | $183,000 | -51.5% | 12,021 | -0.3% | 0.00% | -100.0% |
Q2 2018 | $377,000 | – | 12,056 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $9,074,000 | 1.96% |
NEA Management Company, LLC | 4,912,306 | $49,025,000 | 0.99% |
RA Capital Management | 4,871,067 | $48,613,000 | 0.86% |
Samsara BioCapital, LLC | 345,293 | $3,446,000 | 0.67% |
Endurant Capital Management LP | 197,462 | $1,971,000 | 0.48% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,867,467 | $18,637,000 | 0.39% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $274,000 | 0.20% |
Baker Brothers Advisors | 3,863,239 | $38,555,000 | 0.19% |
Rock Springs Capital Management LP | 627,180 | $6,259,000 | 0.14% |
Aquatic Capital Management LLC | 4,000 | $40,000 | 0.08% |